Biotech · Private company · Tracys Landing, MD, US
Arkayli Biopharma, Inc.
Track this companyFree. Adds Arkayli Biopharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Clinical Development of ARK001 Formulation as a Targeted Therapeutic for InfantileHemangiomaFiscal year 2026 · $999.9KNIH RePORTER 1R44HL184627-01 · fetched Nov 12, 2026
- Developing a topical beta blocker formulation as a targeted therapeutic for infantile hemangiomaFiscal year 2025 · $306.8KNIH RePORTER 1R41HL177866-01A1 · fetched Nov 12, 2026